Aubra Eq Kit
Product Images NDC 63629-5651

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Aubra Eq (NDC 63629-5651). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636295651)

Aubra EQ kit label with Levonorgestrel 0.1 mg and Ethinyl Estradiol 0.02 mg per tablet. The label states the package contains six blister cards, each with 28 tablets. It includes storage instructions and manufacturer Bryant Ranch Prepack and Aurobindo Pharma Limited. The label also displays the NDC 63629-5651-1 and QR codes for additional information.*

FDA Label Image

Figure I: Mean (se) Levonorgestrel And Ethinyl Estradiol Serum Concentrations In 22 Subjects Receiving Levonorgestrel And Ethinyl Estradiol (100 Mcg Levonorgestrel And 20 Mcg Ethinyl Estradiol) (Levo Ethi Fig1)

Pharmacokinetic concentration-time profiles over 72 hours for Levonorgestrel and Ethinyl Estradiol measured on Days 1, 6, and 21. The graphs show mean concentrations (ng/mL) with error bars plotted against time (hours) for each sampling day, illustrating changes in drug plasma levels over time within the dosing period.*

FDA Label Image

Circulatory Disease Mortality Rates Per 100,000 Woman Years By Age, Smoking Status And Oral-contraceptive Use (Levo Ethi Fig2)

A bar chart illustrating circulatory disease mortality rates per 100,000 woman years categorized by age groups, smoking status, and oral contraceptive use. The chart compares four groups: ever-users (nonsmokers), controls (nonsmokers), ever-users (smokers), and controls (smokers) across age ranges 15-24, 25-34, 35-44, and 45 and older.*

FDA Label Image

Levo-ethi-fig3 (Levo Ethi Fig3)

A forest plot chart showing effect estimates (odds ratios/risk ratios) with confidence intervals from various studies, including NICHD Women's Contraceptive Study, French E3N cohort Study, Shangai Women's Health Study, Nurses' Health Study II, Oxford Family Planning Association Study, and Danish Sex Hormone Register Study. The chart compares estimates for ever use and current use, with values centered around 1.0 on the effect estimate axis.*

FDA Label Image

Levo-ethi-fig4 (Levo Ethi Fig4)

An illustrated dosing calendar for Aubra EQ (Levonorgestrel and Ethinyl Estradiol Tablets USP 0.1 mg/0.02 mg) showing four weekly rows of circular tablet positions labeled by days Sunday to Saturday. The first three weeks contain white to off-white circles, and the fourth week contains green circles, indicating different tablet colors for each week. Arrows guide the sequence of tablet use through the weeks, with a note that tablets in week 4 are inactive.*

FDA Label Image

Levo-ethi-fig5 (Levo Ethi Fig5)

Instructional diagram showing how to select and place the correct day label for Aubra EQ levonorgestrel and ethinyl estradiol tablets kit. The illustrated hand peels a day label strip (e.g., MON through FRI) to place on the kit. The kit layout shows four weekly rows of pill slots with arrows indicating the order of use and color-coded pills, with the fourth week containing green tablets marked as inactive.*

FDA Label Image

Levo-ethi-fig6 (Levo Ethi Fig6)

An instructional diagram for Aubra EQ (Levonorgestrel and Ethinyl Estradiol) tablet pack showing a 4-week pill schedule. It features four rows labeled 1 to 4, each corresponding to a week, with Sunday to Saturday days of the week across the top. Weeks 1 to 3 show white to off-white circles indicating active tablets, and week 4 shows green circles indicating inactive tablets. Arrows guide the tablet-taking order starting at week 1, Sunday.*

FDA Label Image

Levo-ethi-fig7 (Levo Ethi Fig7)

Illustration showing how to apply a day label strip (MON to SUN) to a medication kit blister pack for Aubra EQ (Levonorgestrel and Ethinyl Estradiol tablets USP 0.1 mg/0.02 mg). The diagram includes 4 weekly rows of pill slots with arrows indicating the order of taking tablets, highlighting that tablets in week 4 are inactive. A hand is depicted placing the day label on the pack.*

FDA Label Image

Chemical Structure (Levo Ethi Str)

Chemical structures of Levonorgestrel and Ethinyl Estradiol are shown, depicting the molecular formulas and bonding arrangements of these active pharmaceutical ingredients found in the product Aubra EQ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.